CN
News & Events
Rare Diseases and Advanced Technologies Forum Kicks off in Suzhou
News & Events CBIIC 2023.10.11 354

12-1.jpg

Zhang Zhijuan, deputy director of Policy Research Center of PhIRDA chaired the first stage.

22-1.jpg

Li Linkang, vice chairman and expert Committee on Diagnosis, Treatment and Support of Rare Diseases of the National Health Commission made a welcome remark.

22-2.jpg

Han Xiaohong, professor and director of Clinical Pharmacology Research Center, Peking Union Medical College Hospital shared Trends in Clinical Trials of Rare Diseases in China.

22-3.jpg

Chen Jia, director of Gene Editing Center, ShanghaiTech University addressed a keynote speech entitled Development and Application of New Gene Editing Tools.

22-4.jpg

Zhao Yuan, Chief Technology Officer of Jiangsu Hillgene, addressed a keynote speech entitled The Impact of EU/US Regulatory Framework on CGT Development.

22-5.jpg

Val Su, head of New Product Development Takeda China, addressed a keynote speech entitled New Ecology of Transformation on Rare Diseases Drug R&D.

22-6.jpg

Rebecca Zhang, senior vice president, Pharmaceutical Affairs, Canbridge Pharma, addressed a keynote speech entitled China Rare Disease New Drug Development Challenge and Thinking.

22-7.jpg

Liu Junshuai, member of Specialty Committee on Diagnosis, Treatment and Protection of Rare Diseases, was moderator of the panel discussion. Chen Jia, Zhang Dan, co-Founder and co-Chairman of Jiangsu Hillgene, Eileen Gu, associate director, Takeda China, and Rebecca Zhang, participated in the panel.

22-8.jpg